ICP Das Co., Ltd. (TPEX:3577)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
96.80
-0.50 (-0.51%)
Aug 12, 2025, 1:30 PM CST

Ligand Pharmaceuticals Revenue

ICP Das had revenue of 293.10M TWD in the quarter ending June 30, 2025, with 16.45% growth. This brings the company's revenue in the last twelve months to 1.19B, up 17.29% year-over-year. In the year 2024, ICP Das had annual revenue of 1.07B with 5.12% growth.

Revenue (ttm)
1.19B
Revenue Growth
+17.29%
P/S Ratio
5.38
Revenue / Employee
n/a
Employees
n/a
Market Cap
6.42B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20241.07B52.18M5.12%
Dec 31, 20231.02B-204.53M-16.72%
Dec 31, 20221.22B181.24M17.40%
Dec 31, 20211.04B283.91M37.46%
Dec 31, 2020757.99M-23.73M-3.04%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition